title: Phosphorylated neurofilament heavy chain correlations to visual function, optical coherence tomography, and treatment.
abstract: Objective. To correlate visual and neurologic clinical scores and treatment of optic neuritis and multiple sclerosis (MS) patients with assays of serum phosphorylated neurofilament heavy chain (pNF-H) and optical coherence tomography (OCT) measurements of axonal loss. Design/Methods. The Optic Neuritis Treatment Trial (ONTT) randomized 457 patients with acute optic neuritis to intravenous methylprednisolone (IVMP) followed by oral prednisone, oral prednisone or placebo treatment arms. We quantified serum pNF-H levels in 175 ONTT patients 5 years after study entry. We performed OCT measurements of macular volume and the retinal nerve fiber layer (RNFL) in a subset of 51 patients at year 15. Results. Elevated pNF-H levels at year 5 correlated to poorer visual function at study entry. Lower 15 year macular volumes and RNFL thickness correlated better with follow-up than with baseline visual function measures. With IVMP treatment, 15 year RNFL differences of the fellow eye (FE) minus the affected eye (SE) RNFLFEmSE correlated with five-year pNF-H levels. PNF-H was reduced by half with IVMP relative to placebo or by 40% relative to prednisone. Conclusions/Relevance. Acute optic neuritis patients who have more severe visual loss during initial presentation have a higher incidence of axonal loss that was slightly suppressed with IVMP treatment.
authors.affiliation: Bascom Palmer Eye Institute, Miller School of Medicine, University of Miami, 1638 NW 10th Avenue, Miami, Fl 33136, USA.
authors.forename: Joshua
authors.initials: J
authors.lastname: Pasol
authors.forename: William
authors.initials: W
authors.lastname: Feuer
authors.forename: Cui
authors.initials: C
authors.lastname: Yang
authors.forename: Gerry
authors.initials: G
authors.lastname: Shaw
authors.forename: Randy
authors.initials: R
authors.lastname: Kardon
authors.forename: John
authors.initials: J
authors.lastname: Guy
references.citation: J Neuroimmunol. 2006 Sep;178(1-2):40-8
references.pmid: 16828169
references.citation: Ophthalmology. 2008 Jun;115(6):1079-1082.e5
references.pmid: 17976727
references.citation: Arch Ophthalmol. 1995 Feb;113(2):136-7
references.pmid: 7864737
references.citation: J Neurosci Res. 2008 Dec;86(16):3548-55
references.pmid: 18709652
references.citation: N Engl J Med. 1998 Jan 29;338(5):278-85
references.pmid: 9445407
references.citation: Neurology. 2009 Apr 14;72(15):1322-9
references.pmid: 19365053
references.citation: Neurology. 2007 Apr 17;68(16):1299-304
references.pmid: 17438220
references.citation: N Engl J Med. 1993 Dec 9;329(24):1764-9
references.pmid: 8232485
references.citation: Brain. 2006 Jun;129(Pt 6):1507-16
references.pmid: 16597651
references.citation: Science. 1991 Nov 22;254(5035):1178-81
references.pmid: 1957169
references.citation: Biochem Biophys Res Commun. 2005 Nov 4;336(4):1268-77
references.pmid: 16176808
references.citation: J Immunol Methods. 2007 Jan 30;319(1-2):34-40
references.pmid: 17140597
references.citation: Arch Ophthalmol. 1997 Dec;115(12):1545-52
references.pmid: 9400788
references.citation: Am J Ophthalmol. 2004 Jan;137(1):77-83
references.pmid: 14700647
references.citation: Neurology. 2001 Oct 9;57(7):1248-52
references.pmid: 11591844
references.citation: Invest Ophthalmol Vis Sci. 2010 Mar;51(3):1439-45
references.pmid: 19892867
references.citation: J Neurol Sci. 2003 Feb 15;206(2):165-71
references.pmid: 12559505
references.citation: Ophthalmology. 1996 Nov;103(11):1889-98
references.pmid: 8942887
references.citation: J Neuroimmunol. 2003 May;138(1-2):45-8
references.pmid: 12742652
references.citation: Ann Neurol. 2005 Sep;58(3):383-91
references.pmid: 16075460
references.citation: J Neurol Neurosurg Psychiatry. 2004 Aug;75(8):1178-80
references.pmid: 15258226
references.citation: Mult Scler. 2006 Jun;12(3):325-8
references.pmid: 16764346
references.citation: J Neurol Sci. 2005 Jun 15;233(1-2):183-98
references.pmid: 15896809
references.citation: Mol Vis. 2008;14:2443-50
references.pmid: 19104679
references.citation: N Engl J Med. 1992 Feb 27;326(9):581-8
references.pmid: 1734247
references.citation: Graefes Arch Clin Exp Ophthalmol. 2010 Dec;248(12):1777-85
references.pmid: 20300766
references.citation: J Neurochem. 2009 Dec;111(5):1182-91
references.pmid: 19765193
references.citation: Arch Soc Esp Oftalmol. 2010 Jun;85(6):209-14
references.pmid: 21074096
references.citation: Ann Neurol. 2006 Jun;59(6):963-9
references.pmid: 16718705
references.citation: Invest Ophthalmol Vis Sci. 2007 Feb;48(2):681-91
references.pmid: 17251466
references.citation: J Neurosci. 2003 Aug 6;23(18):6993-7000
references.pmid: 12904460